tiprankstipranks
Innovent Biologics (HK:1801)
:1801
Hong Kong Market
1801
Innovent Biologics
RESEARCH TOOLSreports
Want to see HK:1801 full AI Analyst Report?

Innovent Biologics (1801) Cash flow

26 Followers

Innovent Biologics Cash Flow

HK:1801's free cash flow for Q4 2025 was ¥9.43B. For the 2025 fiscal year, HK:1801's free cash flow was decreased by ¥9.74B and operating cash flow was ¥9.66B. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
¥ 10.00B¥ 1.29B¥ 147.81M¥ -1.92B¥ -2.02B
Investing Cash Flow
¥ -6.51B¥ -1.17B¥ -998.66M¥ -1.44B¥ -2.70B
Financing Cash Flow
¥ 4.73B¥ -606.63M¥ 2.59B¥ 2.89B¥ 5.00B
End Cash Position
¥ 10.38B¥ 2.27B¥ 2.75B¥ 1.02B¥ 1.36B
Free Cash Flow
¥ 9.32B¥ -418.39M¥ -1.24B¥ -3.30B¥ -3.87B
Currency in CNY

Innovent Biologics Cash Flow